Neil Mody

Neil Mody is a formulation scientist within the dosage form design and development department at AstraZeneca. He has 15+ years of experience with broad expertise in formulation development and analytical and process characterization strategies for multiple molecular modalities including peptides, enzymes, fusion proteins, mAbs, multispecifics, circuits and engagers, and antibody-drug conjugates. In his current role, Neil and his team are responsible for leading novel molecule formulation and computational technology development initiatives.